Cookie Use Notification

This site uses cookies to provide you with a more responsive and personalised service.

By using this site you agree to our use of cookies as set out in our cookie notice. Please read our cookie notice for more information on the cookies we use and how to delete or block the use of cookies.

Novo Nordisk is a new tenant at The Park Warsaw

Click to Enlarge

The Park Warsaw, a modern office complex, has signed up a new tenant. Novo Nordisk, a leading Danish healthcare company, will occupy a 1,830 sq m office. Global real estate services firm Cushman & Wakefield advised the tenant on the choice of the new location.

The Park Warsaw is a complex of 10 class A office buildings with a total lease area of 110,000 sq m. It boasts a high standard and a BREEAM certificate with an Excellent rating. It is located close to Warsaw airport and major communication arteries: Hynka/Łopuszańska streets and Krakowska Avenue.

“The Park Warsaw is one of the most modern office projects in Warsaw. The campus offers on-site amenities including a canteen, a retail store and an ATM, which will soon be complemented by a fitness club and a kindergarten. It is an excellent example of a project which - in addition to incorporating green features and the latest trends in office design - ensures user comfort. I am confident that both Novo Nordisk and other tenants of the complex will be very pleased with their choice,” said Daniel Kłosowski, Senior Negotiator, Office Agency, Cushman & Wakefield.

Novo Nordisk is a global pharmaceutical company with 95 years of innovation and leadership in diabetes care. It also has a leading position in haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs over 43,100 people in 79 countries and markets its products in more than 170 countries. Novo Nordisk is a listed company traded at NASDAQ Copenhagen: Novo-B. ADRs are listed at the New York Stock Exchange (NVO).